INTERPROTEIN

We believe that we can change this situation with our twin proprietary technologies; INterprotein's ENgine for new Drug Design, (INTENDD®) , a structure-based drug discovery (SBDD) strategy for small molecules, and helix-loop-helix peptide, a conformationally-constrained peptide with a unique modality... With twin platform technologies, Interprotein provides highly active modulators for protein-protein interaction (PPI) targets... At Interprotein, we strive to revolutionize drug discovery with our expertise in analyzing and exploiting protein-protein interaction (PPI) interfaces to design and create PPI modulators. Targeting PPIs for therapeutic intervention with small molecules have long been postulated as plausible, but the number of authentic PPI inhibitors on the market is limited.

Also known as: Interprotein Corporation

Primary location: Osaka Japan